Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells.
We reported previously that insulin inhibits the stimulatory effect of high glucose on the expression of angiotensinogen (ANG) gene in both rat immortalized renal proximal tubular cells (IRPTCs) and non-diabetic rat renal proximal tubular cells (RPTCs), but has no effect in diabetic rat RPTCs. In the present study we investigated whether hyperglycaemia-induced resistance to the insulin-induced inhibition of expression of the ANG gene is mediated via the generation of reactive oxygen species (ROS) in RPTCs. Rat IRPTCs were cultured for 2 weeks in high-glucose (25 mM) or normal-glucose (5 mM) medium plus angiotensin II (Ang II) with or without a superoxide scavenger (tiron), or inhibitors of: NADPH oxidase (diphenylene iodinium, DPI), Ang II type 1 and 2 receptors (losartan and PD123319), angiotensin-converting enzyme (perindopril), protein kinase C (GF 109203X), or glutamine:fructose-6-phosphate amino-transferase (azaserine). Cellular generation of ROS, and ANG and renin mRNA levels were assessed by lucigenin assay and specific reverse transcriptase-PCR respectively. Phosphorylation of p44/42 mitogen-activated protein kinase (p44/42 MAPK) was evaluated by western blotting. Prolonged exposure of IRPTCs to high concentrations of glucose or Ang II evoked generation of ROS and resistance to the insulin-induced inhibition of expression of the ANG gene and of p44/42 MAPK phosphorylation. Co-incubation of IRPTCs with tiron, DPI, losartan, PD123319, perindopril, GF 109203X or azaserine prevented ROS generation, restoring the inhibitory action of insulin on ANG gene expression and on p44/42 MAPK phosphorylation. In conclusion, our studies demonstrate that blockade of both ROS generation and activation of the intrarenal renin-angiotensin system improves the inhibitory action of insulin on ANG gene expression in IRPTCs in conditions of high glucose.
Hsieh
Tusty-Jiuan
TJ
Research Centre, Centre hospitalier de l'Université de Montréal (CHUM), Hôtel-Dieu, 3850 Saint Urbain Street, Montreal, Quebec H2W 1T8, Canada.
Fustier
Pierre
P
Wei
Chih-Chang
CC
Zhang
Shao-Ling
SL
Filep
Janos G
JG
Tang
Shiow-Shiu
SS
Ingelfinger
Julie R
JR
Fantus
I George
IG
Hamet
Pavel
P
Chan
John S D
JS
D014013:1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000808:Angiotensinogen / Q000235:genetics*; D000818:Animals; D001377:Azaserine / Q000494:pharmacology; D002460:Cell Line; D005786:Gene Expression Regulation / Q000187:drug effects*; D005947:Glucose / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology; D007202:Indicators and Reagents / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism*; D007687:Kidney Tubules, Proximal / Q000378:metabolism*; D019808:Losartan / Q000494:pharmacology; D008301:Maleimides / Q000494:pharmacology; D020913:Perindopril / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism*; D012083:Renin / Q000235:genetics
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D007093:Imidazoles; D007202:Indicators and Reagents; D007211:Indoles; D007328:Insulin; D008301:Maleimides; D011725:Pyridines; D017382:Reactive Oxygen Species; D000808:Angiotensinogen; D000804:Angiotensin II; C073402:PD 123319; D014013:1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; D001377:Azaserine; D011493:Protein Kinase C; D012083:Renin; D005947:Glucose; D019808:Losartan; C070515:bisindolylmaleimide I; D020913:Perindopril